Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979327 · ClinicalTrials.gov registry record · Phase 4
Cardiovascular Effects of Adderall in Healthy Adults.
A Phase 4 study of Cardiovascular System and Hemodynamics, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02979327 is a Phase 4 study of Cardiovascular System and Hemodynamics that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02979327, a Phase 4 study of Cardiovascular System and Hemodynamics, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.
Conditions Studied
Interventions
- DRUG Placebo capsule
- DRUG Adderall capsule
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-07-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02979327
The ClinicalTrials.gov registry entry for NCT02979327 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular System appearing as the primary indexed condition, and to 2 interventions - of which Placebo capsule is the first listed.
NCT02979327 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02979327 about?
NCT02979327 is a clinical study titled "Cardiovascular Effects of Adderall in Healthy Adults.". This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.
What is the current status of trial NCT02979327?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2018-06-01. Estimated completion is 2021-07-23.
What conditions does trial NCT02979327 study?
This clinical trial studies the following conditions: Cardiovascular System, Hemodynamics.
What interventions are being tested in trial NCT02979327?
The interventions under investigation include: Placebo capsule (DRUG), Adderall capsule (DRUG).
Who is sponsoring clinical trial NCT02979327?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02979327 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular System
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.